Letters
Bevacizumab prescription by ophthalmologists
The NHS must act on bevacizumab, for patients’ sake
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5427 (Published 29 November 2017) Cite this as: BMJ 2017;359:j5427
- Greg Fell, director of public health
- Town Hall, Sheffield S1 2HH, UK
- greg.fell{at}sheffield.gov.uk
The Royal College of Ophthalmologists has taken a definitive view on the longstanding subject of bevacizumab for macular degeneration.12 Four further actions could be taken.
Firstly, the law might be clarified. This could be in court or the Department of Health could directly intervene. The General Medical Council could be asked to clarify its position in light of the recent …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.